Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
-
Brown Plus Named a Top Regional Firm in the Mid-Atlantic on Accounting Today's list of the Top 100 Firms and Regional Leaders in 2024
-
MDC INDUSTRY HOLDING COMPANY LLC ANNOUNCES AMENDMENTS TO ITS US$130,000,000 IN CONVERTIBLE NOTES OF EQUINOX GOLD CORP.
-
Aqua Metals Announces 2024 Annual Meeting of Stockholders
-
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
-
Sonya K. Zeigler, Esq. Opens Full-Service Firm Zeigler Law Group, LLC
-
Monster Energy's Liz Akama Takes First Place in Women's Skateboard Street at SLS Apex 01 Competition in Las Vegas
-
새로운 면역원성 위험 평가 플랫폼 ISPRI, 생물학적 치료제 개발 촉진
-
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
-
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
-
GCT Semiconductor Appoints Nelson C. Chan to Board of Directors
-
Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available
-
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
-
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
-
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Air Premia Joins TSA PreCheck® Program, Expediting Security Screening for U.S. Travelers
-
Vallen Distribution Completes Acquisition of Wesco Integrated Supply
-
Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023
-
The Shop Men's Grooming Line Is Now Available Nationwide
-
Next Bridge Hydrocarbons Announces Transactions
-
Guerrilla RF Reports Record Revenue for Fourth Quarter and Full Year 2023
-
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
-
Zinnia Closes Acquisition of Ebix’s North American Life and Annuity Assets
-
SPAR Group, Inc. Reports Fourth Quarter and Full Year Fiscal 2023 Results
-
H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical
-
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development
-
Sarah Jessica Parker Faces A Dilemma Of Grand Proportion In New Campaign For Solitaire Grand Harvest
-
Scienjoy Subsidiary, Scienjoy Meta Technology L.L.C, Introduces AI Mate & AI Vision: Entering a New Era of Predictive Personal Assistance
-
Soluna to Present at the AI & Technology Hybrid Investor Conference Presented by Water Tower Research on April 10
-
Lots of Peddling in Kansas City's West Bottoms From Bikes to Shops
-
Sprott Announces Expense Ratio Reduction for Sprott Uranium Miners ETF (NYSE Arca: URNM)
-
Haemonetics Corporation Completes Acquisition of Attune Medical
-
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
-
Daqo New Energy's Subsidiary Xinjiang Daqo Proposes 2023 Cash Dividend for Approval at Its Annual Shareholders' Meeting
-
Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
-
Silfab Solar Names Trevor Carson as Chief Financial Officer
-
CIBC continues commitment to affordable housing with latest project: Thrive on King
-
New Kentucky Law Will Protect Homebuyers from Predatory Contracts
-
Results of New Study Reveal the Importance of Multiple Financial Education Interventions
-
d'Alba's Vegan Beauty Revolution: White Truffle Spray Serum Takes Global Market by Storm
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Littlejohn & Co. Acquires United Air Temp, Air Conditioning and Heating
-
XRHealth Awarded Contract with Israeli Police To Deploy Solution in Every Police Station Throughout Israel to Promote Mental Health Resilience
-
Herc Holdings Inc. Announces Nomination of Lorin Crenshaw to Board of Directors
-
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
-
Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease
-
Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions
-
HDBank announces financial statements with profit of $524 million, ROE 24.2%, releases 2024 ESG report
-
Browning West’s Slate of Highly Qualified Director Candidates Releases Five-Pillar Plan to Enhance Shareholder Value at Gildan Activewear
-
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency


